STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,098 | -66.3% | 7,893 | -9.0% | 0.02% | -65.5% |
| Q2 2023 | $92,247 | -8.3% | 8,678 | -28.2% | 0.06% | 0.0% |
| Q1 2023 | $100,610 | -34.8% | 12,078 | -27.7% | 0.06% | -32.1% |
| Q4 2022 | $154,279 | +20.5% | 16,715 | +67.7% | 0.08% | +58.8% |
| Q3 2022 | $128,000 | -2.3% | 9,970 | +0.8% | 0.05% | +4.1% |
| Q2 2022 | $131,000 | -27.2% | 9,895 | +15.6% | 0.05% | -39.5% |
| Q1 2022 | $180,000 | -17.4% | 8,559 | -5.6% | 0.08% | -1.2% |
| Q4 2021 | $218,000 | +55.7% | 9,070 | +64.8% | 0.08% | +32.3% |
| Q3 2021 | $140,000 | -28.2% | 5,502 | -4.9% | 0.06% | -22.5% |
| Q2 2021 | $195,000 | -6.2% | 5,786 | +7.9% | 0.08% | -9.1% |
| Q1 2021 | $208,000 | -36.2% | 5,361 | +1.8% | 0.09% | -34.8% |
| Q4 2020 | $326,000 | – | 5,264 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 17,161,713 | $666,561,000 | 74.20% |
| RTW INVESTMENTS, LP | 3,644,248 | $141,543,000 | 2.21% |
| Redmile Group, LLC | 2,544,062 | $98,811,000 | 1.39% |
| Cormorant Asset Management, LP | 1,437,807 | $55,844,000 | 1.24% |
| ACUTA CAPITAL PARTNERS, LLC | 45,000 | $1,748,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,729 | $5,854,000 | 0.45% |
| HighVista Strategies LLC | 13,692 | $532,000 | 0.40% |
| Birchview Capital, LP | 15,000 | $583,000 | 0.35% |
| Perceptive Advisors | 671,978 | $26,100,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,265,950 | $49,169,000 | 0.26% |